NMD4C Launch Educational Platform LEARNMD
NMD4C is thrilled to introduce LEARNMD, an online educational platform offering talks and sessions on a wide range of neuromuscular topics presented by leading clinical and scientific experts worldwide. This platform is designed to provide Canadian clinicians and researchers at every career stage with high-quality training and educational resources tailored to their specific neuromuscular interests.
LEARNMD offers a self-directed personalized learning experience tailored to learners’ specific interests, covering neuromuscular disorders, translational and clinical research, therapies, and management strategies. The platform hosts hundreds of educational resources, including recordings of our monthly accredited series and others from organizations we have partnered with. LEARNMD will be regularly updated with new content, ensuring access to the latest research developments and clinical updates.
If you are a Canadian clinician, researcher, and member of the NMD4C we invite you to create a LEARNMD user profile for free. Sign up for the platform here!
We are seeking to build the library of content available in LEARNMD – If you have delivered or attended any neuromuscular-related talks that you think should be included, please reach out to let us know! For any questions about the LEARNMD platform, please contact education and curriculum coordinator Victoria Larocca at
Read next...
NMD4C Hosts 3rd Annual Basic Research Summer School at uOttawa!
From June 8 to 10, 2026, we hosted the 3rd annual NMD4C Basic Research Summer School at the University of Ottawa. The program supported 28 neuromuscular research trainees (graduate students and postdoctoral fellows) from across Canada and focused on developing practical skills, strengthening core knowledge in neuromuscular research, and providing opportunities to present and discuss their work. Through a combination of tutorials, lectures, hands-on workshops in cutting-edge wet lab techniques, flash talks, and both structured and informal networking, participants engaged with faculty, exchanged ideas, and built connections across institutions and career stages.
New Publication from the NMD4C Clinical Trial Network Strengthens Trial Capacity in Canada
We are pleased to share a new publication from the NMD4C Clinical Trial Network led by Kerri Lynn Schellenberg, Homira Osman, Maria Masnata, Rhiannon Hicks, Corinne Kagan, Ana Stosic, Stacey Lintern, Erin Beattie, Drs. Hanns Lochmüller, Craig Campbell, and Jean K Mah. This work focuses on the implementation of a coordinated Canadian neuromuscular clinical trial network to enhance trial readiness, capacity, and access in rare disease research.
Canadian-Led Phase II Studies Advance Vamorolone Evidence in Duchenne Muscular Dystrophy
NMD4C investigators contributed to two phase II studies evaluating vamorolone in boys with Duchenne muscular dystrophy across early childhood and adolescence, demonstrating safety, favorable pharmacokinetics, and potential efficacy. Led by Dr. Jean Mah and conducted across Canadian clinical trial sites with national and industry collaborators, the findings supported Health Canada approval of vamorolone as the first treatment for DMD in Canada. Leaders from both the clinical and patient advocacy communities, including Defeat Duchenne Canada, highlighted the impact of collaboration among patients, families, clinicians, and researchers in advancing care and improving access to new therapies.